Home / Market News / $STIM
benzinga Corporate Catalyst Impact 55/100 ● neutral

BTIG Reiterates Buy on Neuronetics, Maintains $6 Price Target

Sep 9, 2026, 10:22 AM UTC · Primary ticker $STIM

This filing discloses that BTIG analyst Sam Eiber has reiterated a 'Buy' rating and maintained a $6 price target for Neuronetics. This indicates continued analyst confidence in the company's prospects, which could provide some positive sentiment for investors.

BTIG analyst Sam Eiber reiterated a 'Buy' rating and maintained a $6 price target for Neuronetics (STIM). This action signals continued analyst confidence in the company's financial performance and future growth potential. For traders, this could provide a short-term positive sentiment boost, potentially leading to increased buying interest. While not a new catalyst, the reaffirmation of a positive outlook can reinforce existing investment theses. The long-term implications depend on whether Neuronetics can meet or exceed the expectations embedded in this price target. The key opportunity for traders is to potentially capitalize on any positive momentum generated by this analyst endorsement.

$STIM positive Analyst reiterates Buy rating and price target
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.